Cryoport Projects 2026 Revenue Between $192M and $196M
CYRX has more than doubled off its 52-week low of $5.31.
Summary
Cryoport, Inc. has issued its revenue guidance for fiscal year 2026, forecasting sales to be in the range of $192 million to $196 million. This guidance provides a crucial forward-looking metric for investors and analysts to assess the company's expected top-line performance and growth prospects. This is new, material information that directly impacts financial models and investment theses, as it was not previously disclosed in the recent SEC filings or news within the provided timeline. Professional traders would need to incorporate this guidance immediately to update their valuations and adjust their positions.
At the time of this announcement, CYRX was trading at $10.62 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $512.5M. The 52-week trading range was $5.31 to $11.45. This news item was assessed with neutral market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.